@PatrickM42

Statistician and epidemiologist, formerly of @LSHTM now at @NICEComms

 London
Joined August 2011
  • Tweets19
  • Following84
  • Followers44
Delighted to lead the #CHAIhub with @GlockerBen (@imperialcollege), @HanaChockler (@KingsCollegeLon), @MattSperrin (@UniversityManch ), @SabinaLeonelli (@UniofExeter), Ricardo Silva (@ucl). We will bring together #academia and #industry for #causal #AI for #health real data 1/2
School of Engineering@SchoolOfEng_UoE6 Feb 2024
🎉 We’re leading on two new #AI hubs! Thanks to £24m funding from @UKRI_news, our academics @STsaftaris will be Director of the CHAI AI Hub focusing on #causalAI in #healthcare & @themispr will be Director of the APRIL AI Hub for #electronics. Congrats! edin.ac/3uuUFsH
6
7
2
62
13,369
Patrick Muller retweeted
greg
@greg166769354206 Nov 2023
AI vs Blueberry, a thread:
391
538
156
7,365
1,986,154
Risk of premature birth up to 50% higher in mothers with poor mental health according to 🆕 research in @TheLancetPsych 🧠 ✍️ @ipeet @PatrickM42 @JanvanderMeule6 & colleagues @KingsCollegeLon @RCObsGyn @StGeorgesUni @dmuleicester @LivUni @Sydney_Uni 👉 bit.ly/3ODA9fK
9
2
11
3,132
Patrick Muller retweeted
PLOS Medicine@PLOSMedicine20 Jul 2023
Patrick Muller, Amar M Karia & colleagues investigate adverse outcomes in women with low-risk pregnancies undergoing induction of labour at 39 weeks, according to ethnicity, socioeconomic deprivation and parity: doi.org/10.1371/journal.pmed… @PatrickM42 @NeonatalNurstin @ipeet
1
2
4
900
It’s not about the money
653
13,771
3,600
55,334
Patrick Muller retweeted
PLOS Medicine@PLOSMedicine11 Jan 2022
Ipek Gurol-Urganci & colleagues study obstetric intervention rates and pregnancy outcomes in England during the first year of the COVID-19 pandemic: doi.org/10.1371/journal.pmed… @profasmakhalil @RCObsGyn @NMPA_audit @CRRDMU @PatrickM42 @ipeet @jenejardine #pregnancy #COVID
5
8
#COVID19 dogs could revolutionise how we detect the virus. But these clever canines need your help getting odour samples 🐕‍🦺 If you've taken a positive #PCR test in the past 3⃣ days, find out how you can volunteer 👉 bit.ly/32T9NSA @MedDetectDogs @durham_uni
COVID-19 Medical Detection Dog

ALT COVID-19 Medical Detection Dog

COVID-19 Medical Detection Dog

ALT COVID-19 Medical Detection Dog

31
1
33
Patrick Muller retweeted
NMPA@nmpa_audit11 Nov 2021
Published today our sprint audit on Ethnic and Socio-economic Inequalities in Maternity and Perinatal Care. Read the report here: maternityaudit.org.uk/FilesU… @RCObsGyn @HQIP @LSHTM @MidwivesRCM @RCPCHtweets
2
23
6
34
Patrick Muller retweeted
Ipek Gurol Urganci@ipeet2 Nov 2021
Stark racial and social inequalities in pregnancy outcomes in over a million births | LSHTM lshtm.ac.uk/newsevents/news/… @jenejardine @PatrickM42 @JanvanderMeule6 @ProfAsmaKhalil @NeonatalNurstin

Stark racial and social inequalities in pregnancy outcomes in over a million

Large inequalities in pregnancy outcomes between ethnic and socioeconomic groups in England, according to a nationwide study of over one million births in the English National Health Service (NHS)

lshtm.ac.uk
4
7
Patrick Muller retweeted
Jen Jardine@jenejardine2 Nov 2021
New paper in @TheLancet using @nmpa_audit data estimates the proportion of adverse birth outcomes (stillbirth, preterm birth, and fetal growth restriction) in England that are attributable to socioeconomic & ethnic inequality. Read here: authors.elsevier.com/a/1e081… @RCObsGyn @LSHTM
4
79
9
155
Now available fully open access in AJOG: our cohort study on how 10-year reoperation risk varies between women who had different initial surgical treatments for stress urinary incontinence. ajog.org/article/S0002-9378(…
1
Its taken 8 years to publication today! Thanks to the colleagues, funders and patients who made this possible. 3fold fewer #lupus flares with belimumab after Rituximab @VersusArthritis⁩ ⁦@UCLHresearch⁩ ⁦@GSK⁩ ⁦@ucl⁩ ⁦@LUPUSUK⁩ acpjournals.org/doi/10.7326/…

Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus: A Randomized Controlled...

Background: B-cell depletion with rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. We...

acpjournals.org
4
30
1
77
Patrick Muller retweeted
Muge Cevik
@mugecevik21 Dec 2020
There are several reasons to think that the new UK #SARSCoV2 variant is an important one as it might be more contagious than other variants, but there are also some uncertainties. So much misinformation is being circulated, so this thread brings key data together. 🧵
181
3,497
897
8,964
The BEAT-LUPUS trial analysis plan is now published! Will evaluate anti-dsDNA and flares, and whether effect of belimumab is mediated through steroid dose changes. Results later in 2020. @MikeEhrenstein @CarolinendLupus @UCL_CCTU @VersusArthritis trialsjournal.biomedcentral.…

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus...

Trials - There is limited evidence that rituximab, a B cell depletion therapy, is an effective treatment for systemic lupus erythematosus (SLE). Data on the mechanisms of B cell depletion in SLE...

link.springer.com
4
11
SAP published for the KERALINK trial, testing the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients aged 10–16 years. Results expected later this year! #keratoconus trialsjournal.biomedcentral.…

Corneal cross-linking versus standard care in children with keratoconus – a randomised, multicent...

Trials - The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients aged...

link.springer.com
1
1
3
Published this week in Cancer Epidemiology 'Temporal and geographic changes in stage at diagnosis in England during 2008–2013: A population-based study of colorectal, lung and ovarian cancers'. Research by @icon_lshtm's @PatrickM42 Check it out here!: sciencedirect.com/science/ar…
2
3
Patrick Muller retweeted
Suzie Cro@Suzie_cro19 Feb 2020
Great to see the statistical analysis plan for the @TARVA_Trial published! #transparency Looking forward to seeing the results! Total ankle replacement vs arthrodesis for end-stage ankle osteoarthritis 🦶 @PatrickM42 @ssskene rdcu.be/b1U1w
1
1
7
Load more